Regulatory News
Monday, December 12, 2016
BRIEF-Flexion Therapeutics submits new drug application for Zilretta to treat knee osteoarthritis pain
* Submits new drug application for Zilretta to treat knee
osteoarthritis pain
Source text for Eikon:
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment